BGC vs EXAS · P/E 40, rev $1.80B vs rev $2.76B
BGC Group Inc. (BGC) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
BGC Group Inc. (BGC) is a capital markets company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported BGC revenue for 2026-06-30 was $1.80B. Net income was $156.6M. Revenue was up 88.5% from 2026-03-31 to 2026-06-30. BGC currently screens at market cap $5.09B and trailing P/E 40.1.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
BGC currently screens at market cap $5.09B and trailing P/E 40.1. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the BGC and EXAS stock pages for the full models.
Not investment advice.